Expert warns of the continuous dangers posed by polio and other enteroviruses

Na­tion­al Re­silience was hand­ed a Form 483 in No­vem­ber not­ing that the man­u­fac­tur­er did not prop­er­ly re­view or ad­dress mold-con­t­a­m­i­nat­ed prod­uct batch­es, and it may

Tra­vere Ther­a­peu­tics won full ap­proval for Filspari, which treats a rare au­toim­mune dis­ease that af­fects the kid­neys. Filspari, al­so known as sparsen­tan, re­ceived an ac­cel­er­at­ed